Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...

Weight loss drugs continue to make headlines.  A new study conducted by researchers from the University of Southern ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ingredient, they are approved for different purposes. Ozempic is primarily ...

There are also plenty of clinical trials on Ozempic and Wegovy, and these studies show that semaglutide can be an effective weight loss treatment for people with and without diabetes. For instance ...

Findings showed semaglutide 7.2mg demonstrated a statistically significant and superior weight loss compared with placebo at week 72. Topline data were announced from a phase 3b trial evaluating ...

This week, Novo Nordisk announced that people taking its mega-dose version of semaglutide ... prescribed off-label for weight loss. In large-scale, placebo-controlled trials of Wegovy, people ...

A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

It’s possible to experience significant, disruptive side effects while taking semaglutide for weight loss. Clinical trials have reported discontinuation rates (people quitting the medication ...

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.